Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-2-5
|
pubmed:abstractText |
The efficacy of concurrent radiochemotherapy should be evaluated in term of therapeutic ratio. The aims of treatment are increasing local control and possibly overall survival. Acute toxicity should be reported using the WHO recommendations, while late toxicity is reported using the scales recommended by the EORTC and RTOG Radiotherapy Groups. Moreover, functional, esthetic and quality of life considerations should be introduced. The application of these treatments needs a well-designed multidisciplinary staff.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1278-3218
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
665-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9922770-Antineoplastic Agents,
pubmed-meshheading:9922770-Chemotherapy, Adjuvant,
pubmed-meshheading:9922770-Combined Modality Therapy,
pubmed-meshheading:9922770-Humans,
pubmed-meshheading:9922770-Neoadjuvant Therapy,
pubmed-meshheading:9922770-Neoplasms,
pubmed-meshheading:9922770-Quality of Life,
pubmed-meshheading:9922770-Radiation Dosage,
pubmed-meshheading:9922770-Radiation-Sensitizing Agents,
pubmed-meshheading:9922770-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
[Clinical evaluation of concomitant chemoradiotherapy and practical recommendations].
|
pubmed:affiliation |
Service de radiothérapie-oncologie, CHU Jean-Minjoz, Besançon, France.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|